Ronald Plasterk verkoopt zijn start-up aan Duitse vaccinmaker CureVac Het Financieele Dagblad - 09 Jun 2022 Ronald Plasterk verkoopt zijn start-up aan Duitse vaccinmaker CureVac ... More
Duitse farmaceut CureVac koopt start-up Ronald Plasterk voor 32 miljoen NRC - 09 Jun 2022 Duitse farmaceut CureVac koopt start-up Ronald Plasterk voor 32 miljoen ... More
Lezersvragen: Hoe werken de RNA-vaccins van Pfizer, Moderna en CureVac? NU.nl - 27 Nov 2020 Lezersvragen: Hoe werken de RNA-vaccins van Pfizer, Moderna en CureVac? ... More
Start klinisch onderzoek nieuw COVID-19 vaccin UMC Utrecht - 21 Dec 2020 Start klinisch onderzoek nieuw COVID-19 vaccin ... More
'Vaccin ontwikkelen duurt normaal 10 tot 15 jaar. Wij zijn in januari begonnen' AD - 25 Apr 2020 'Vaccin ontwikkelen duurt normaal 10 tot 15 jaar. Wij zijn in januari begonnen' ... More
Curevac speurt met Gentse spitstechnologie naar kankervaccins De Tijd - 26 May 2022 Curevac speurt met Gentse spitstechnologie naar kankervaccins ... More
Vijfde coronavaccin op komst: wat is er speciaal aan CureVac en waarom liet het zo lang op zich wachten? Het Nieuwsblad - 04 May 2021 Vijfde coronavaccin op komst: wat is er speciaal aan CureVac en waarom liet het zo lang op zich wachten? ... More
Plasterk: denkbaar dat dodelijke ziekten behandelbaar worden wnl.tv - 25 Dec 2022 Plasterk: denkbaar dat dodelijke ziekten behandelbaar worden ... More
CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech CureVac - 19 May 2023 CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech ... More
German Federal Patent Court changes its mind on CureVac mRNA patent JUVE Patent - 19 Dec 2023 German Federal Patent Court changes its mind on CureVac mRNA patent ... More
Coronavirus: Commission offers financing to innovative vaccines company CureVac European Commission - 16 Mar 2020 Coronavirus: Commission offers financing to innovative vaccines company CureVac ... More
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government CureVac - 11 Apr 2022 CureVac and GSK Enter into Pandemic Preparedness Contract with German Government ... More
CureVac files vaccine patent infringement claim against BioNTech in Düsseldorf JUVE Patent - 07 Jul 2022 CureVac files vaccine patent infringement claim against BioNTech in Düsseldorf ... More
CureVac Named as One of the World's Most Dynamic Innovators by LexisNexis® CureVac - 31 Jan 2023 CureVac Named as One of the World's Most Dynamic Innovators by LexisNexis® ... More
Düsseldorf Regional Court waits for validity judgments in CureVac v BioNTech JUVE Patent - 17 Aug 2023 Düsseldorf Regional Court waits for validity judgments in CureVac v BioNTech ... More
CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board CureVac - 20 Jun 2023 CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board ... More
CureVac Announces Financial Results for the Third Quarter of 2022 and Provides Business Update CureVac - 16 Nov 2022 CureVac Announces Financial Results for the Third Quarter of 2022 and Provides Business Update ... More
CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma CureVac - 20 Jun 2023 CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma ... More